Leqembi: A New Era in Medication-Based Alzheimer’s Treatment
On July 6, 2023, the US Food and Drug Administration granted approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the devastating memory-loss disease.…
On July 6, 2023, the US Food and Drug Administration granted approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the devastating memory-loss disease.…